Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)
NCT07425561
Bacterial Infections, Bacterial Infections and Mycoses
Florence, Italy
View Trial DetailsNCT Number: NCT01336036
This is a descriptive clinical research aiming:
* To describe the clinical spectrum and clinical characteristics of community acquired pneumonia (CAP) in patients admitted to hospital * To identify the etiology of CAP and the antibiotic sensitivity of the isolated organisms * To identify the risk factors that influence the severity of CAP
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
National Hospital of Tropical Diseases, Hanoi, Vietnam
In Vietnam, the range and relative contribution of organisms causing CAP remain unclear, largely because diagnostic tools are limited and clinical research uncommon. An improved understanding of the risk factors, etiology and clinical outcomes of CAP in Vietnam would contribute to improved approaches to patient diagnosis and clinical management. This will be achieved by following the clinical and laboratory progress and treatment outcomes of in-patients diagnosed with CAP from admission to discharge. Comparative analyses will be between subgroups including survivor and non-survivor, severe CAP and non-severe CAP, known etiology and unknown etiology, SIRS, sepsis, severe sepsis and shock septic.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 14 days
Time frame: 14 days
Proportion of patients who die at Day 14
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Length of stay from admission to discharge in days
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Oxford University Clinical Research Unit, Vietnam
Other
Etiology, Clinical Manifestations and Risk Factors for Community-acquired Pneumonia in Patients Admitted to Hospital
Acronym: CAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07425561
Bacterial Infections, Bacterial Infections and Mycoses
Florence, Italy
View Trial DetailsNCT07336121
Bronchial Diseases, Bronchiolitis
Cairo, Egypt
View Trial DetailsNCT02517489
Community Acquired Pneumonia, Community-Acquired Infections
Angoulême, France
View Trial DetailsNCT06210282
Community Acquired Pneumonia, Community-Acquired Infections
Gistrup, Denmark
View Trial Details